EMD (EMD) Stock Price & Analysis
EMD (EMD) fell 0.14% to USD 10.47 as of July 26, 2026 at 22:56 UTC, according to Nexqual real-time market data.
EMD last closed at USD 10.49; the session ranged USD 10.43–10.58 on volume of 153,970 shares. Market capitalization is —, with a 52-week range of USD 9.6–11.3 (NYQ). Source: Nexqual, July 26, 2026 at 22:56 UTC.
Key Statistics (as of July 26, 2026 at 22:56 UTC)
| Price | USD 10.47 |
|---|---|
| Change | ▼ 0.14% (down) |
| Previous Close | USD 10.49 |
| Open | USD 10.49 |
| Day Range | USD 10.43 – 10.58 |
| 52-Week Range | USD 9.6 – 11.3 |
| Volume | 153,970 shares |
| Market Cap | — |
| Exchange | NYQ |
Technical Analysis (EMD)
Nexqual's technical model rates EMD "SELL" based on 2 bullish and 5 bearish signals across 125 daily candles, as of July 26, 2026 at 22:56 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 42.59 (neutral) |
| vs SMA50 | Below (USD 10.58) |
| MACD | -0.01 (negative) |
Analyst Ratings (EMD)
Wall Street analysts rate EMD "None", per Nexqual as of July 26, 2026 at 22:56 UTC.
| Consensus Rating | None |
|---|
Earnings (EMD)
Source: Nexqual, July 26, 2026 at 22:56 UTC.
Financials & Fundamentals (EMD)
| Total Revenue | $68.09M |
|---|---|
| Revenue Growth (YoY) | -3.00% |
| Gross Margin | +100.00% |
| Operating Margin | +87.08% |
| Profit Margin | +148.51% |
| ROE | +15.93% |
| Debt / Equity | 36.55 |
| Current Ratio | 0.07 |
| Total Cash | $39,708 |
| Total Debt | $238.77M |
| Free Cash Flow | $31.74M |
Source: Nexqual, July 26, 2026 at 22:56 UTC.
Financial Health Score (EMD)
Nexqual rates EMD's overall financial health "Solid" across five dimensions, as of July 26, 2026 at 22:56 UTC.
| Growth | Weak — Revenue -3% YoY (latest Q), declining |
|---|---|
| Profitability | Strong — Operating margin 87% |
| Balance Sheet | Mixed — $40K cash vs $239M debt |
| Cash Flow | Strong — FCF $32M, 47% margin |
| Efficiency | Solid — ROE 16%, ROA 4.3% |
Ownership (EMD)
| Insider Ownership | +0.00% |
|---|---|
| Institutional Ownership | +45.40% |
| Short % of Float | +0.22% |
Source: Nexqual, July 26, 2026 at 22:56 UTC.
Leadership (EMD)
EMD is led by Jane Elizabeth Trust (age 63), Chairman, Chief Executive Officer and President, per Nexqual as of July 26, 2026 at 22:56 UTC.
| Chairman, Chief Executive Officer and President | Jane Elizabeth Trust (age 63) |
|---|
Major Backers & Investors (EMD)
Notable institutional backers of EMD include Morgan Stanley, Invesco, Raymond James Financial, Inc., according to Nexqual as of July 26, 2026 at 22:56 UTC.
Active Investors
| Investor | Stake |
|---|---|
| Morgan Stanley | 15.5% |
| Invesco | 2.38% |
| Raymond James Financial, Inc. | 1.66% |
| Pathstone Holdings, LLC | 1.56% |
| LPL Financial LLC | 1.44% |
| Penserra Capital Management LLC | 1.31% |
| Amplify ETF Trust-Amplify CEF High Income ETF | 1.3% |
| Wells Fargo & Company | 1.29% |
Source: Nexqual, July 26, 2026 at 22:56 UTC.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| EDF | Stone Harbor Emerging Markets I | USD 5.11 | ▼ 1.92% |
| MSD | Morgan Stanley Emerging Markets | USD 7.27 | ▼ 0.68% |
| EHI | Western Asset Global High Incom | USD 5.79 | ▼ 2.2% |
| TEI | Templeton Emerging Markets Inco | USD 6.57 | ▼ 2.52% |
| AWF | Alliancebernstein Global High I | USD 10.06 | ▼ 0.79% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: July 26, 2026 at 22:56 UTC. This page is informational and not investment advice.